News about Global Pharma

Glenmark Life Sciences Rebrands its Identity as Alivus Life Sciences

The new identity, Alivus Life Sciences, represents vitality and growth with a renewed focus.

Global Pharma | 20/01/2025 | By Aishwarya |  3157

India Restricts Import of Refurbished Medical Devices Due to Regulatory Gaps

This move highlights India's stringent approach toward medical device regulation, ensuring that only new, certified devices meeting quality and safety standards enter the market.

Global Pharma | 20/01/2025 | By Aishwarya |  470

Freudenberg Medical Announces Appointment of Michael McGee as New CEO

Michael McGee, former COO, assumed the role of Chief Executive Officer, succeeding Dr. Mark Ostwald, who transitioned to another leadership role within the Freudenberg Group.

Global Pharma | 20/01/2025 | By Aishwarya |  255

MalarVx Partners with HDT Bio to Advance repRNA/LION Malaria Vaccine Technology

MalarVx, Inc. has licensed HDT Bio's self-amplifying replicon RNA and LION technologies to develop potent, durable, and cost-effective malaria vaccines.

Global Pharma | 18/01/2025 | By Manvi |  244

Concord Biotech to Use Renewable Energy in its Dholka Facility to Promote Sustainability

Ahmedabad-based pharmaceutical company Concord Biotech will procure 9.9 MW wind-solar hybrid power from Clean Max Enviro Energy Solutions (CleanMax), marking its first investment in renewable energy to power its manufacturing plant at Dholka in Gujarat.

Global Pharma | 18/01/2025 | By Manvi |  620

Mytos Signs Manufacturing Deal with Aspen Neuroscience in Parkinson?s Disease

As part of the partnership agreement, Aspen will integrate Mytos’ iDEM automated cell culture technology into its new manufacturing facility in Torrey Pines, Calif.

Global Pharma | 18/01/2025 | By Aishwarya |  226

SCHOTT Pharma Introduces Next Gen Polymer Syringe System

Developed with SCHOTT Pharma's Alliance to Zero partners, Schreiner MediPharm and Körber Pharma, the system consists of a new cap, a functional label, and a carton packaging.

Global Pharma | 18/01/2025 | By Aishwarya |  347

AstraZeneca Gains CDSCO Nod for Import of Eculizumab in India

Eculizumab is a monoclonal antibody used to treat Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) by inhibiting complement-mediated thrombotic microangiopathy.

Global Pharma | 18/01/2025 | By Aishwarya |  357

IDT Biologika Welcomes Federico Pollano as New Chief Commercial Officer

Federico Pollano has extensive experience in management positions at global CDMOs in the pharmaceutical and biotechnology industry.

Global Pharma | 18/01/2025 | By Aishwarya |  509

FDA Approves First Mesenchymal Stromal Cell Therapy 'RYONCIL'

The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in children two months and older.

Global Pharma | 17/01/2025 | By Manvi |  544